ACTIVE

SOCIETE DE GESTION D'INVESTISSEMENT, DE CONSEIL ET DE REALISATION

Financial year 2025 · Closed on 31/12/2025

Net result206,2 k €+4 135,6 %over 1 year
Gross margin232,7 k €+19 194,4 %over 1 year
Equity66,7 k €+10,3 %over 1 year
Workforce0,0 ETP

Identity

Source · BCE/KBO

SOCIETE DE GESTION D'INVESTISSEMENT, DE CONSEIL ET DE REALISATION is a Private limited company incorporated in 1992. Its main activity is: Technical testing and analysis. Its registered office is in Namur.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0446.373.907
Incorporation
20/01/1992
Legal form
Private limited company
Registered office
Rue Joseph Durieux(BL) 133
5001 Namur · WallonieSee on map
Contributed capital
33 785,12 €
Latest accounts
31/12/2025
Average workforce
0,0 ETP
Joint committees (2)
  • 100
  • 218
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 19 financial years

20252024202320222020
Income statement
Gross margin232,7 k €-1,2 k €-26,6 k €7,4 k €18,3 k €
EBITDA212,6 k €-21,3 k €-33,7 k €3,8 k €14,3 k €
Operating result224,2 k €6,3 k €-40 k €-38,9 k €3,1 k €
Net result206,2 k €4,9 k €-42,9 k €-40,8 k €1,9 k €
Balance sheet
Equity66,7 k €60,5 k €55,6 k €98,5 k €414,7 k €
Total assets293,9 k €86,5 k €74,4 k €122,4 k €428,2 k €
Cash242,4 k €46,5 k €12,8 k €31,4 k €27,3 k €
Debts227 k €25,6 k €14,4 k €23,8 k €13,5 k €
Other
Workforce0,0 ETP––––

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 66 ended

Active mandates

DirectorFunctionMandateOther mandatescurrentendedstruck offbankruptcies
Fréderic DAUCHE
Director24/06/2024 → 15/07/2028
000
Isabelle Eimer
Director15/07/2022 → 15/07/2028
00

Ended mandates

DirectorFunctionMandateOther mandatescurrentendedstruck offbankruptcies
Stéphane Eimer
Director10/12/2021 → 22/06/2022
00
Analyses de Biologie Clinique Dubois Emmanuel0824.254.827Represented by Emmanuel DUBOIS
Directorsince 15/11/2019
000
Analyses de Biologie Clinique Dubois Emmanuel0824.254.827Represented by Emmanuel DUBOIS
Directorsince 15/11/2019
000
Biologie Médicale Lebrun0898.265.629Represented by John LEBRUN
Directorsince 15/11/2019
000

Other companies at this address

Rue Joseph Durieux(BL) 133 5001 Namur
CompanyCBE no.
0439.256.976

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202614/07/202524/07/202405/10/202307/09/202225/08/2021
General meeting29/05/202630/06/202511/07/202404/10/202322/08/202218/08/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/05/202630/06/2026FrenchPDF
Abridged model31/12/202430/06/202514/07/2025FrenchPDF
Abridged model31/12/202311/07/202424/07/2024FrenchPDF
Abridged model31/12/202204/10/202305/10/2023FrenchPDF
Abridged model31/12/202122/08/202207/09/2022FrenchPDF
Abridged model31/12/202018/08/202125/08/2021FrenchPDF
Abridged model31/12/201929/09/202029/10/2020FrenchPDF
Abridged model31/12/201819/06/201929/08/2019FrenchPDF
Abridged model31/12/201714/06/201831/08/2018FrenchPDF
Abridged model31/12/201628/03/201717/08/2017FrenchPDF
Abridged model31/12/201507/06/201611/08/2016FrenchPDF
Abridged model31/12/201402/06/201511/08/2015FrenchPDF
Abridged model31/12/201320/06/201421/08/2014FrenchPDF
Abridged model31/12/201227/06/201323/08/2013FrenchPDF
Abridged model31/12/201112/06/201224/08/2012FrenchPDF
Abridged model31/12/201007/06/201118/08/2011FrenchPDF
Abridged model31/12/200926/05/201027/07/2010FrenchPDF
Abridged model31/12/200802/06/200925/08/2009FrenchPDF
Abridged model31/12/200710/06/200817/07/2008FrenchPDF
Abridged model31/12/200605/06/200718/06/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 66 ended

Active mandates

DirectorFunctionMandateOther mandatescurrentendedstruck offbankruptcies
Fréderic DAUCHE
Director24/06/2024 → 15/07/2028
000
Isabelle Eimer
Director15/07/2022 → 15/07/2028
00

Ended mandates

DirectorFunctionMandateOther mandatescurrentendedstruck offbankruptcies
Stéphane Eimer
Director10/12/2021 → 22/06/2022
00
Analyses de Biologie Clinique Dubois Emmanuel0824.254.827Represented by Emmanuel DUBOIS
Directorsince 15/11/2019
000
Analyses de Biologie Clinique Dubois Emmanuel0824.254.827Represented by Emmanuel DUBOIS
Directorsince 15/11/2019
000
Biologie Médicale Lebrun0898.265.629Represented by John LEBRUN
Directorsince 15/11/2019
000

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates25/11/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates05/09/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates30/12/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates31/08/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates27/01/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Restructuring11/06/2021
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Restructuring09/04/2021
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Mandates09/12/2019
    DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025206,2 k €↑
  2. 2024
    Annual accounts 20244,9 k €↑
  3. 2023
    Annual accounts 2023-42,9 k €↓
  4. 2022
    Annual accounts 2022-40,8 k €↓
  5. 2022
    Name changeGICR
  6. 2020
    Annual accounts 20201,9 k €↑
  7. 2019
    Annual accounts 2019-84,2 k €↓
  8. 2018
    Annual accounts 201826,4 k €↓
  9. 2017
    Annual accounts 2017934,9 k €↑
  10. 2016
    Annual accounts 2016314,7 k €↑
  11. 2015
    Annual accounts 201520,2 k €↓
  12. 2014
    Annual accounts 2014324,6 k €↑
  13. 2013
    Annual accounts 201336,5 k €↑
  14. 2012
    Annual accounts 201218,3 k €↓
  15. 2011
    Annual accounts 201133,5 k €↑
  16. 2010
    Annual accounts 201028,8 k €↓
  17. 2009
    Annual accounts 200934,6 k €↑
  18. 2008
    Annual accounts 200817,1 k €↑
  19. 2007
    Annual accounts 200714 k €↑
  20. 2006
    Annual accounts 20061,9 k €
  21. 20/01/1992
    IncorporationPrivate limited company

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
SOCIETE DE GESTION D'INVESTISSEMENT, DE CONSEIL ET DE REALISATIONCurrent
CBE, tracked since 27/09/2026
CBE
GICR
accounts 2022 → 2025
Accounts 2025 · 2026-00226318
SOCIETE DE GESTION D'INVESTISSEMENT, DE CONSEIL ET DE REALISATION
accounts 2006 → 2020
Accounts 2020 · 2021-53700584

Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.